Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study

  • Podlipnik, Sebastian|||0000-0003-4150-0522
  • Carrera, Cristina|||0000-0003-1608-8820
  • Boada, Aram|||0000-0001-9809-5308
  • Richarz, Nina
  • Marcoval, Joaquim|||0000-0002-6489-1872
  • Ferreres, Josep Ramón
  • Bodet, Domingo|||0000-0003-2227-0696
  • Martí, Rosa María|||0000-0001-6866-6114
  • Segura, Sonia|||0000-0003-0653-1382
  • Sabat Santandreu, Mireia|||0000-0003-2583-5138
  • Dalmau-Arias, Joan
  • Quintana, Mònica
  • Azon, Antoni|||0000-0003-3112-552X
  • Curcó, Neus
  • Formigon, Manel
  • Olivella-Garcés, María Rosa
  • Zaballos, Pedro
  • Sola, Joaquim
  • Galvany, Loida
  • Baliu-Piqué, Carola
  • Alegre Fernández, Marta|||0000-0003-4718-4831
  • Pasquali, Paola
  • Malvehy, Josep|||0000-0002-6998-914X
  • Puig, Susana|||0000-0003-1337-9745
The incidence of melanoma has been increasing worldwide during recent decades. The objective of the study was to analyse the trends in incidence for in situ and invasive melanoma in the Spanish region of Catalonia during the period of 2008-2017. We designed a cross-sectional study with an age-period-cohort analysis of melanoma patient data from the Network of Melanoma Centres in Catalonia. Our database covered a population of over seven million and included a total of 8626 patients with incident melanoma. The main outcome measures were crude and age-standardised incidence rates to the European 2013 standard population. Joinpoint regression models were used to evaluate the population trends. We observed an increase in the age-standardised incidence rate (per 100,000 population) of all melanoma subtypes from 11.56 in 2008 to 13.78 in 2017 with an average annual percent change (AAPC) of 3.5%. This incidence increase was seen exclusively in the older population. Moreover, the stratified analysis showed a statistically significant increase in the age-standardised incidence rate for invasive (AAPC 2.1%) and in situ melanoma (AAPC 6.5%). In conclusion, the incidence of melanoma has continued to increase in the elderly population over recent decades, with a rapidly increasing trend of in situ melanomas and the lentigo maligna subtype.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma, A Multicenter Propensity Score Matching Study

  • Tejera-Vaquerizo, Antonio|||0000-0002-8987-0744
  • Boada, Aram|||0000-0001-9809-5308
  • Ribero, Simone
  • Puig, Susana|||0000-0003-1337-9745
  • Paradela, Sabela|||0000-0002-6779-6459
  • Moreno-Ramírez, David|||0000-0002-1301-7974
  • Cañueto, Javier
  • de Unamuno-Bustos, Blanca
  • Brinca, Ana
  • Descalzo-Gallego, Miguel A.
  • Osella-Abate, Simona|||0000-0002-9886-7694
  • Cassoni, Paola|||0000-0003-1977-7410
  • Podlipnik, Sebastian|||0000-0003-4150-0522
  • Carrera, Cristina|||0000-0003-1608-8820
  • Vidal-Sicart, Sergi|||0000-0002-6303-3606
  • Pigem, Ramón|||0000-0002-3224-8241
  • Toll Abelló, Agustí|||0000-0003-2656-0076
  • Rull, Ramón|||0000-0002-8345-4598
  • Alos, Llucìa|||0000-0002-3460-0384
  • Requena, Celia
  • Bolumar, Isidro
  • Traves, Víctor
  • Pla, Ángel
  • Fernández-Orland, Almudena
  • Jaka, Ane|||0000-0003-2699-1159
  • Fernández-Figueras, Maria Teresa|||0000-0002-2366-7110
  • Richarz, Nina Anika|||0000-0003-0027-8769
  • Vieira, Ricardo
  • Botella-Estrada, Rafael
  • Román-Curto, Concepción|||0000-0001-6147-9412
  • Ferrándiz-Pulido, Lara
  • Iglesias-Pena, Nicolás|||0000-0002-7282-5015
  • Ferrándiz, Carlos|||0000-0001-9030-8399
  • Malvehy, Josep|||0000-0002-6998-914X
  • Quaglino, Pietro
  • Nagore, Eduardo|||0000-0003-3433-8707
The therapeutic value of sentinel lymph node biopsy (SLNB) in thin melanoma remains controversial. The aim of this study is to determine the role of SLNB in the survival of thin melanomas (≤1 mm). A multicenter retrospective observational study was designed. A propensity score matching was performed to compare patients who underwent SLNB vs. observation. A multivariate Cox regression was used. A total of 1438 patients were matched by propensity score. There were no significant differences in melanoma-specific survival (MSS) between the SLNB and observation groups. Predictors of MSS in the multivariate model were age, tumor thickness, ulceration, and interferon treatment. Results were similar for disease-free survival and overall survival. The 5- and 10-year MSS rates for SLN-negative and -positive patients were 98.5% vs. 77.3% (p < 0.001) and 97.3% vs. 68.7% (p < 0.001), respectively. SLNB does not improve MSS in patients with thin melanoma. It also had no impact on DSF or OS. However, a considerable difference in MSS, DFS, and OS between SLN-positive and -negative patients exists, confirming its value as a prognostic procedure and therefore we recommend discussing the option of SLNB with patients.